₹ 990.57 Cr
0.21%
NIFTY Pharma TRI
INF204KC1089
1000.0
0.0
100
Jitendra Tolani
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Nippon India Nifty Pharma ETF | -0.45 | 20.39 | - |
| Nifty Pharma TRI | 0.76 | 20.93 | 15.19 |
Equity
Debt
Others
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 21.62 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 10.88 |
| Dr. Reddys Laboratories Ltd | 9.59 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 9.3 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 5.95 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.85 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 4.21 |
| ALKEM LABORATORIES LIMITED EQ | 3.93 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 3.9 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 3.78 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.97 |
| Scheme Name | 5Y (%) |
|---|---|
| Nippon India Nifty Pharma ETF | 0.0 |
| UTI Silver ETF | 0.0 |
| ICICI Pru Gold ETF | 18.03 |
| HDFC Gold ETF | 17.94 |
| Quantum Gold Fund | 17.85 |
| Axis Gold ETF | 18.05 |
| Invesco India Gold ETF | 18.09 |
| Mirae Asset Gold ETF | 0.0 |
| SBI Gold ETF | 17.89 |
| LIC MF Gold Exchange Traded Fund | 18.33 |